[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Actinic Keratosis Market - Global Outlook and Forecast 2021-2027

April 2021 | 106 pages | ID: A6A054BE5F3DEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Actinic Keratosis in Global, including the following market information:

Global Actinic Keratosis Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Actinic Keratosis market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Actinic Keratosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Actinic Keratosis Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Actinic Keratosis Market Segment Percentages, By Type, 2020 (%)
  • Destructive Treatment
  • Photodynamic Therapy
  • Topical Medications
  • Other
China Actinic Keratosis Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Actinic Keratosis Market Segment Percentages, By Application, 2020 (%)
  • Pharmaceutical And Biotechnology Companies
  • Hospital
  • Outpatient Surgical Centers And Clinics
  • Academic And Research Organizations
  • Other
Global Actinic Keratosis Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Actinic Keratosis Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Actinic Keratosis Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Actinic Keratosis Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • DUSA Pharmaceuticals, Inc.
  • Novartis
  • Perrigo Company plc
  • Apotex
  • Tolmar Pharmaceuticals, Inc
  • Vidac Pharma
  • LEO Laboratories
  • Promius Pharma
  • Valeant Pharmaceuticals International, Inc.
  • Aqua Pharmaceuticals, LLC
  • Galderma SA
  • Taro Pharmaceutical Industries
  • Bausch Health
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Actinic Keratosis Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Actinic Keratosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ACTINIC KERATOSIS OVERALL MARKET SIZE

2.1 Global Actinic Keratosis Market Size: 2021 VS 2027
2.2 Global Actinic Keratosis Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Actinic Keratosis Players in Global Market
3.2 Top Global Actinic Keratosis Companies Ranked by Revenue
3.3 Global Actinic Keratosis Revenue by Companies
3.4 Top 3 and Top 5 Actinic Keratosis Companies in Global Market, by Revenue in 2020
3.5 Global Companies Actinic Keratosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Actinic Keratosis Players in Global Market
  3.6.1 List of Global Tier 1 Actinic Keratosis Companies
  3.6.2 List of Global Tier 2 and Tier 3 Actinic Keratosis Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Actinic Keratosis Market Size Markets, 2021 & 2027
  4.1.2 Destructive Treatment
  4.1.3 Photodynamic Therapy
  4.1.4 Topical Medications
  4.1.5 Other
4.2 By Type - Global Actinic Keratosis Revenue & Forecasts
  4.2.1 By Type - Global Actinic Keratosis Revenue, 2016-2021
  4.2.2 By Type - Global Actinic Keratosis Revenue, 2022-2027
  4.2.3 By Type - Global Actinic Keratosis Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Actinic Keratosis Market Size, 2021 & 2027
  5.1.2 Pharmaceutical And Biotechnology Companies
  5.1.3 Hospital
  5.1.4 Outpatient Surgical Centers And Clinics
  5.1.5 Academic And Research Organizations
  5.1.6 Other
5.2 By Application - Global Actinic Keratosis Revenue & Forecasts
  5.2.1 By Application - Global Actinic Keratosis Revenue, 2016-2021
  5.2.2 By Application - Global Actinic Keratosis Revenue, 2022-2027
  5.2.3 By Application - Global Actinic Keratosis Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Actinic Keratosis Market Size, 2021 & 2027
6.2 By Region - Global Actinic Keratosis Revenue & Forecasts
  6.2.1 By Region - Global Actinic Keratosis Revenue, 2016-2021
  6.2.2 By Region - Global Actinic Keratosis Revenue, 2022-2027
  6.2.3 By Region - Global Actinic Keratosis Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Actinic Keratosis Revenue, 2016-2027
  6.3.2 US Actinic Keratosis Market Size, 2016-2027
  6.3.3 Canada Actinic Keratosis Market Size, 2016-2027
  6.3.4 Mexico Actinic Keratosis Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Actinic Keratosis Revenue, 2016-2027
  6.4.2 Germany Actinic Keratosis Market Size, 2016-2027
  6.4.3 France Actinic Keratosis Market Size, 2016-2027
  6.4.4 U.K. Actinic Keratosis Market Size, 2016-2027
  6.4.5 Italy Actinic Keratosis Market Size, 2016-2027
  6.4.6 Russia Actinic Keratosis Market Size, 2016-2027
  6.4.7 Nordic Countries Actinic Keratosis Market Size, 2016-2027
  6.4.8 Benelux Actinic Keratosis Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Actinic Keratosis Revenue, 2016-2027
  6.5.2 China Actinic Keratosis Market Size, 2016-2027
  6.5.3 Japan Actinic Keratosis Market Size, 2016-2027
  6.5.4 South Korea Actinic Keratosis Market Size, 2016-2027
  6.5.5 Southeast Asia Actinic Keratosis Market Size, 2016-2027
  6.5.6 India Actinic Keratosis Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Actinic Keratosis Revenue, 2016-2027
  6.6.2 Brazil Actinic Keratosis Market Size, 2016-2027
  6.6.3 Argentina Actinic Keratosis Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Actinic Keratosis Revenue, 2016-2027
  6.7.2 Turkey Actinic Keratosis Market Size, 2016-2027
  6.7.3 Israel Actinic Keratosis Market Size, 2016-2027
  6.7.4 Saudi Arabia Actinic Keratosis Market Size, 2016-2027
  6.7.5 UAE Actinic Keratosis Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 DUSA Pharmaceuticals, Inc.
  7.1.1 DUSA Pharmaceuticals, Inc. Corporate Summary
  7.1.2 DUSA Pharmaceuticals, Inc. Business Overview
  7.1.3 DUSA Pharmaceuticals, Inc. Actinic Keratosis Major Product Offerings
  7.1.4 DUSA Pharmaceuticals, Inc. Actinic Keratosis Revenue in Global (2016-2021)
  7.1.5 DUSA Pharmaceuticals, Inc. Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Actinic Keratosis Major Product Offerings
  7.2.4 Novartis Actinic Keratosis Revenue in Global (2016-2021)
  7.2.5 Novartis Key News
7.3 Perrigo Company plc
  7.3.1 Perrigo Company plc Corporate Summary
  7.3.2 Perrigo Company plc Business Overview
  7.3.3 Perrigo Company plc Actinic Keratosis Major Product Offerings
  7.3.4 Perrigo Company plc Actinic Keratosis Revenue in Global (2016-2021)
  7.3.5 Perrigo Company plc Key News
7.4 Apotex
  7.4.1 Apotex Corporate Summary
  7.4.2 Apotex Business Overview
  7.4.3 Apotex Actinic Keratosis Major Product Offerings
  7.4.4 Apotex Actinic Keratosis Revenue in Global (2016-2021)
  7.4.5 Apotex Key News
7.5 Tolmar Pharmaceuticals, Inc
  7.5.1 Tolmar Pharmaceuticals, Inc Corporate Summary
  7.5.2 Tolmar Pharmaceuticals, Inc Business Overview
  7.5.3 Tolmar Pharmaceuticals, Inc Actinic Keratosis Major Product Offerings
  7.5.4 Tolmar Pharmaceuticals, Inc Actinic Keratosis Revenue in Global (2016-2021)
  7.5.5 Tolmar Pharmaceuticals, Inc Key News
7.6 Vidac Pharma
  7.6.1 Vidac Pharma Corporate Summary
  7.6.2 Vidac Pharma Business Overview
  7.6.3 Vidac Pharma Actinic Keratosis Major Product Offerings
  7.6.4 Vidac Pharma Actinic Keratosis Revenue in Global (2016-2021)
  7.6.5 Vidac Pharma Key News
7.7 LEO Laboratories
  7.7.1 LEO Laboratories Corporate Summary
  7.7.2 LEO Laboratories Business Overview
  7.7.3 LEO Laboratories Actinic Keratosis Major Product Offerings
  7.4.4 LEO Laboratories Actinic Keratosis Revenue in Global (2016-2021)
  7.7.5 LEO Laboratories Key News
7.8 Promius Pharma
  7.8.1 Promius Pharma Corporate Summary
  7.8.2 Promius Pharma Business Overview
  7.8.3 Promius Pharma Actinic Keratosis Major Product Offerings
  7.8.4 Promius Pharma Actinic Keratosis Revenue in Global (2016-2021)
  7.8.5 Promius Pharma Key News
7.9 Valeant Pharmaceuticals International, Inc.
  7.9.1 Valeant Pharmaceuticals International, Inc. Corporate Summary
  7.9.2 Valeant Pharmaceuticals International, Inc. Business Overview
  7.9.3 Valeant Pharmaceuticals International, Inc. Actinic Keratosis Major Product Offerings
  7.9.4 Valeant Pharmaceuticals International, Inc. Actinic Keratosis Revenue in Global (2016-2021)
  7.9.5 Valeant Pharmaceuticals International, Inc. Key News
7.10 Aqua Pharmaceuticals, LLC
  7.10.1 Aqua Pharmaceuticals, LLC Corporate Summary
  7.10.2 Aqua Pharmaceuticals, LLC Business Overview
  7.10.3 Aqua Pharmaceuticals, LLC Actinic Keratosis Major Product Offerings
  7.10.4 Aqua Pharmaceuticals, LLC Actinic Keratosis Revenue in Global (2016-2021)
  7.10.5 Aqua Pharmaceuticals, LLC Key News
7.11 Galderma SA
  7.11.1 Galderma SA Corporate Summary
  7.11.2 Galderma SA Business Overview
  7.11.3 Galderma SA Actinic Keratosis Major Product Offerings
  7.11.4 Galderma SA Actinic Keratosis Revenue in Global (2016-2021)
  7.11.5 Galderma SA Key News
7.12 Taro Pharmaceutical Industries
  7.12.1 Taro Pharmaceutical Industries Corporate Summary
  7.12.2 Taro Pharmaceutical Industries Business Overview
  7.12.3 Taro Pharmaceutical Industries Actinic Keratosis Major Product Offerings
  7.12.4 Taro Pharmaceutical Industries Actinic Keratosis Revenue in Global (2016-2021)
  7.12.5 Taro Pharmaceutical Industries Key News
7.13 Bausch Health
  7.13.1 Bausch Health Corporate Summary
  7.13.2 Bausch Health Business Overview
  7.13.3 Bausch Health Actinic Keratosis Major Product Offerings
  7.13.4 Bausch Health Actinic Keratosis Revenue in Global (2016-2021)
  7.13.5 Bausch Health Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Actinic Keratosis Market Opportunities & Trends in Global Market
Table 2. Actinic Keratosis Market Drivers in Global Market
Table 3. Actinic Keratosis Market Restraints in Global Market
Table 4. Key Players of Actinic Keratosis in Global Market
Table 5. Top Actinic Keratosis Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Actinic Keratosis Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Actinic Keratosis Revenue Share by Companies, 2016-2021
Table 8. Global Companies Actinic Keratosis Product Type
Table 9. List of Global Tier 1 Actinic Keratosis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Actinic Keratosis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Actinic Keratosis Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Actinic Keratosis Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Actinic Keratosis Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Actinic Keratosis Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Actinic Keratosis Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Actinic Keratosis Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Actinic Keratosis Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Actinic Keratosis Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Actinic Keratosis Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Actinic Keratosis Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Actinic Keratosis Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Actinic Keratosis Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Actinic Keratosis Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Actinic Keratosis Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Actinic Keratosis Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Actinic Keratosis Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Actinic Keratosis Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Actinic Keratosis Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Actinic Keratosis Revenue, (US$, Mn), 2022-2027
Table 30. DUSA Pharmaceuticals, Inc. Corporate Summary
Table 31. DUSA Pharmaceuticals, Inc. Actinic Keratosis Product Offerings
Table 32. DUSA Pharmaceuticals, Inc. Actinic Keratosis Revenue (US$, Mn), (2016-2021)
Table 33. Novartis Corporate Summary
Table 34. Novartis Actinic Keratosis Product Offerings
Table 35. Novartis Actinic Keratosis Revenue (US$, Mn), (2016-2021)
Table 36. Perrigo Company plc Corporate Summary
Table 37. Perrigo Company plc Actinic Keratosis Product Offerings
Table 38. Perrigo Company plc Actinic Keratosis Revenue (US$, Mn), (2016-2021)
Table 39. Apotex Corporate Summary
Table 40. Apotex Actinic Keratosis Product Offerings
Table 41. Apotex Actinic Keratosis Revenue (US$, Mn), (2016-2021)
Table 42. Tolmar Pharmaceuticals, Inc Corporate Summary
Table 43. Tolmar Pharmaceuticals, Inc Actinic Keratosis Product Offerings
Table 44. Tolmar Pharmaceuticals, Inc Actinic Keratosis Revenue (US$, Mn), (2016-2021)
Table 45. Vidac Pharma Corporate Summary
Table 46. Vidac Pharma Actinic Keratosis Product Offerings
Table 47. Vidac Pharma Actinic Keratosis Revenue (US$, Mn), (2016-2021)
Table 48. LEO Laboratories Corporate Summary
Table 49. LEO Laboratories Actinic Keratosis Product Offerings
Table 50. LEO Laboratories Actinic Keratosis Revenue (US$, Mn), (2016-2021)
Table 51. Promius Pharma Corporate Summary
Table 52. Promius Pharma Actinic Keratosis Product Offerings
Table 53. Promius Pharma Actinic Keratosis Revenue (US$, Mn), (2016-2021)
Table 54. Valeant Pharmaceuticals International, Inc. Corporate Summary
Table 55. Valeant Pharmaceuticals International, Inc. Actinic Keratosis Product Offerings
Table 56. Valeant Pharmaceuticals International, Inc. Actinic Keratosis Revenue (US$, Mn), (2016-2021)
Table 57. Aqua Pharmaceuticals, LLC Corporate Summary
Table 58. Aqua Pharmaceuticals, LLC Actinic Keratosis Product Offerings
Table 59. Aqua Pharmaceuticals, LLC Actinic Keratosis Revenue (US$, Mn), (2016-2021)
Table 60. Galderma SA Corporate Summary
Table 61. Galderma SA Actinic Keratosis Product Offerings
Table 62. Galderma SA Actinic Keratosis Revenue (US$, Mn), (2016-2021)
Table 63. Taro Pharmaceutical Industries Corporate Summary
Table 64. Taro Pharmaceutical Industries Actinic Keratosis Product Offerings
Table 65. Taro Pharmaceutical Industries Actinic Keratosis Revenue (US$, Mn), (2016-2021)
Table 66. Bausch Health Corporate Summary
Table 67. Bausch Health Actinic Keratosis Product Offerings
Table 68. Bausch Health Actinic Keratosis Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Actinic Keratosis Segment by Type
Figure 2. Actinic Keratosis Segment by Application
Figure 3. Global Actinic Keratosis Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Actinic Keratosis Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Actinic Keratosis Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Actinic Keratosis Revenue in 2020
Figure 8. By Type - Global Actinic Keratosis Revenue Market Share, 2016-2027
Figure 9. By Application - Global Actinic Keratosis Revenue Market Share, 2016-2027
Figure 10. By Region - Global Actinic Keratosis Revenue Market Share, 2016-2027
Figure 11. By Country - North America Actinic Keratosis Revenue Market Share, 2016-2027
Figure 12. US Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Actinic Keratosis Revenue Market Share, 2016-2027
Figure 16. Germany Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 17. France Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Actinic Keratosis Revenue Market Share, 2016-2027
Figure 24. China Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 28. India Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Actinic Keratosis Revenue Market Share, 2016-2027
Figure 30. Brazil Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Actinic Keratosis Revenue Market Share, 2016-2027
Figure 33. Turkey Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Actinic Keratosis Revenue, (US$, Mn), 2016-2027
Figure 37. DUSA Pharmaceuticals, Inc. Actinic Keratosis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Novartis Actinic Keratosis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Perrigo Company plc Actinic Keratosis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Apotex Actinic Keratosis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Tolmar Pharmaceuticals, Inc Actinic Keratosis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Vidac Pharma Actinic Keratosis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. LEO Laboratories Actinic Keratosis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Promius Pharma Actinic Keratosis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Valeant Pharmaceuticals International, Inc. Actinic Keratosis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Aqua Pharmaceuticals, LLC Actinic Keratosis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Galderma SA Actinic Keratosis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Taro Pharmaceutical Industries Actinic Keratosis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications